CannaPharmaRX, Inc.
CPMD
$0.003
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -30.93% | -30.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -30.93% | -30.45% | |||
| Cost of Revenue | 1.78% | -61.82% | |||
| Gross Profit | -23.60% | 70.65% | |||
| SG&A Expenses | -0.55% | 205.63% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.40% | -49.91% | |||
| Operating Income | -17.63% | 56.08% | |||
| Income Before Tax | -104.68% | 81.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -104.68% | 81.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -104.68% | 81.54% | |||
| EBIT | -17.63% | 56.08% | |||
| EBITDA | -17.63% | 55.13% | |||
| EPS Basic | -110.00% | 82.14% | |||
| Normalized Basic EPS | -85.71% | 80.00% | |||
| EPS Diluted | -110.00% | 82.14% | |||
| Normalized Diluted EPS | -85.71% | 80.00% | |||
| Average Basic Shares Outstanding | 0.00% | -0.04% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||